Outcomes of Fecal Microbiota Transplantation for Clostridioides difficile Infection in South Australia - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Clinical and Safety Outcomes of Fecal Microbiota Transplantation for Clostridioides difficile Infection in South Australia

  • By

  • Emily C Tucker

  • Bianca Angelica

  • Ryan M Mathias

  • Louisa Edwards

  • Robert V Bryant

  • Samuel P Costello

  • March 13, 2025

Share

Original Source(s)

Outcomes of Fecal Microbiota Transplantation for Clostridioides difficile Infection in South Australia

  • by Emily C Tucker, Bianca Angelica, Ryan M Mathias, Louisa Edwards, Robert V Bryant, Samuel P Costello

  • March 13, 2025

Related Content

Epitope Conservation of AZD5148, a Broadly Neutralizing Anti-Toxin B Monoclonal Antibody, Among Diverse and Global Contemporary Clostridioides difficile Isolates

Decreased Antimicrobial Resistance Gene Richness Following Fecal Microbiota, Live-jslm (REBYOTA®) Administration: Post Hoc Analysis of PUNCH CD3

Correspondence to “Escape Velocity—The Launch of Microbiome Therapies”